Herbert Loong: Challenges and opportunities in developing Lung Cancer Advocacy
Herbert Loong, Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong, reshared the post on LinkedIn by Cancer information.com.hk adding:
“A real pleasure to be able to take part in this patients advocacy conference organised by colleagues from Duke-NUS Medical School and National Cancer Centre Singapore addressing challenges and opportunities in developing lung cancer advocacy and patients empowerment in the region.
Thanks for involving our patients advocates Norman Ng and Cancerinformation.com.hk as well.”
Quoting Cancer information.com.hk’s post:
“Thank you for the invitation to the Hopeful Voices 2024 meeting—advancing lung cancer care through patient advocacy. We are truly honored to be part of this significant event.
Today, we connected with advocates from across the Asia-Pacific region, including representatives from Australia, Hong Kong, India, Taiwan, and Singapore.
Together, we engaged in meaningful discussions focused on vital issues such as stigma, policy changes, and the importance of early detection in our respective countries.
This gathering not only highlighted the diverse challenges we face but also underscored our shared commitment to improving lung cancer care. The exchange of ideas and experiences allowed us to learn from one another, sparking innovative solutions through our collaborative brainstorming sessions.
Though we come from different backgrounds and healthcare systems, we stand united in our mission: to build a better healthcare system and ensure a brighter future for all patients. Together, we aspire to break the stigma surrounding lung cancer, advocate for effective policies, and promote early detection, ultimately leading to better health outcomes.
We leave this meeting invigorated, inspired, and ready to work together towards a common goal.
Thank you once again for the opportunity to contribute to such an important cause.”
Herbert H. F. Loong is the Chair-Elect of the International Affairs Committee, a Scientific Track Member (2022-2024), and the Track Leader for Sarcoma (2023) at the American Society of Clinical Oncology (ASCO). Additionally, he has been promoted to Steering Committee Member at the Lung Cancer Policy Network. Dr. Loong is also the Chairperson of the Asia Pacific Coalition against Lung Cancer, a Board Member of the Connective Tissue Oncology Society, and a Committee Member of the International Association for the Study of Lung Cancer. He is an Associate Professor in the Department of Clinical Oncology at The Chinese University of Hong Kong (CUHK).
More posts featuring Herbert Loong.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023